Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

New Ca2+ pump isoforms generated by alternative splicing of rPMCA2 mRNA
Adamo, Hugo P. , Penniston, John T.

Biochemical Journal | August 13, 2015 | Volume: 283 | Issue: 2 | Pages: 355-359

10.1042/bj2830355 | PMID 1315513 Get It

Alternative splices capable of generating proteins with altered functions were found (by PCR) in isoform 2 of the rat plasma membrane Ca2+ pump. These splices were concentrated in two hypervariable regions. One of these regions, near the N-terminus and the lipid-binding region, could be altered by the insertion of either or both of inserts x and y. Insertion of both x and y would add 45 amino acids to the molecule. The y insert causes the appearance of a rather hydrophobic stretch of amino acids in the middle of a highly polar region. The second variable region begins in the middle of the calmodulin-binding domain. Insertion of 229 nucleotides at this point of the message converts the b form to the a form, which has an altered (and shorter) C-terminus. The calmodulin-binding domain of this shortened form has a less basic character, which would decrease the affinity for calmodulin. The b form of isoenzyme 2 contains relatively weak protein kinase A substrate sequences, such as KQNSS and KNNS. These sequences are eliminated in form a, and a strongly activated kinase substrate sequence, RRQSS, appears in a different place. Different tissues use different combinations of alternative splices, with heart and brain showing the greatest diversity.
Guidelines for determination of the number of prior lines of therapy in multiple myeloma
Richardson, Paul G. , Miguel, Jesús F. San , Rajkumar, S. Vincent , Richardson, Paul Gerard Guy , San-Miguel, Jesus

Blood | August 13, 2015 | Volume: 126 | Issue: 7 | Pages: 921-922

10.1182/blood-2015-05-647636 | PMID 26272048 Get It

Sudden Death in an Adolescent Four Years after Recovery from Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
Quam, JP, Edwards, W. D., Bambara, J F, Luzier, TL, Quam, JP

Journal of Forensic Sciences | August 13, 2015 | Volume: 31 | Issue: 3 | Pages: 1135-1141

10.1520/jfs11124j Get It

Abstract A case is presented of sudden death during physical activity in a 15-year-old boy with clinically inactive mucocutaneous lymph node syndrome (Kawasaki disease). At autopsy, the coronary arteries were involved by multiple aneurysms and obstructive thrombi, and the left ventricular myocardium was extensively scarred. Although Kawasaki disease most commonly occurs in infants and young children, it may be a cause of sudden death in adolescents.
Multiple Schedule of Affective Disorders and Schizophrenia (SADS) in the Assessment of Criminal Defendants
Cunnien, AJ, Rogers, Richard

Journal of Forensic Sciences | August 13, 2015 | Volume: 31 | Issue: 1 | Pages: 222-230

10.1520/jfs11874j Get It

Abstract Psychiatric and psychological assessment of criminal defendants is often complicated by the retrospective nature requiring (1) an overreliance on self-reported data and (2) the need to achieve a high degree of certainty in formulating the diagnosis and subsequent expert opinion within the context of an adversarial evaluation. The Multiple Schedule of Affective Disorders and Schizophrenia (SADS) evaluation involves the application of an extensive diagnostic interview that has demonstrated a high degree of reliability and satisfactory validity in making current and lifetime diagnoses. The multiple SADS entails sequential administrations of the SADS, first to the defendant and later to significant others regarding the defendant's functioning during the time period in question. This comprehensive approach allows for the systematic examination of individual symptoms and the clear delineation of disparities and areas of agreement. Usefulness of the multiple SADS evaluation is exemplified in a case study involving criminal responsibility.
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)
Jackson, Amie E., Mian, Michael , Kalpadakis, Christina , Pangalis, Gerassimos A. , Stathis, Anastasios , Porro, Elena, Conconi, Annarita , Cortelazzo, Sergio, Gaïdano, Gianluca , Guillermo, Armando López, Martinelli, Giovanni , Thiéblemont, Catherine , McPhail, Ellen D. , Copie‐Bergman, Christiane , Jack, Andrew , Campo, Elı́as , Mazzucchelli, Luca, Ristow, Kay M., Cavalli, Franco , Nowakowski, Grzegorz S. , Zucca, Emanuele , Johnson, Peter W, Martelli, Maurizio , Copie-Bergman, Christiane, Pileri, Stefano A, Ristow, Kay, Johnson, Peter , Martelli, Maurizio , McPhail, Ellen Darcy , Pileri, Stefano , Habermann, Thomas M. , Campo, Elías , Gaidano, Gianluca , Zucca, Emanuele

The Oncologist | August 13, 2015 | Volume: 20 | Issue: 10 | Pages: 1149-1153

10.1634/theoncologist.2015-0180 | PMID 26268740 Get It

Abstract Background. The salivary gland is one of the most common sites involved by nongastric, extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT). A large series of patients with long-term follow-up has not been documented. This multicenter, international study sought to characterize the clinical characteristics, treatment, and natural history of salivary gland MALT lymphoma. Methods. Patients with biopsy-confirmed salivary gland MALT lymphoma were identified from multiple international sites. Risk factors, treatment, and long-term outcomes were evaluated. Results. A total of 247 patients were evaluated; 76% presented with limited-stage disease. There was a history of autoimmune disorder in 41%, with Sjögren disease being the most common (83%). Fifty-seven percent of patients were initially treated with local therapy with surgery, radiation, or both; 37 of patients were treated with systemic therapy initially, with 47% of those receiving rituximab; and 6% of patients were observed. The median overall survival (OS) was 18.3 years. The median progression-free survival (PFS) following primary therapy was 9.3 years. There was no difference in the outcomes between patients receiving local or systemic therapy in first-line management. On multivariate analysis, age <60 years and low to intermediate international prognostic index were associated with improved OS and PFS; Sjögren disease was associated with improved OS. Conclusion. Salivary gland MALT lymphoma has an excellent prognosis regardless of initial treatment, and patients with Sjögren disease have improved survival. Risks for long-term complications must be weighed when determining initial therapy. Implications for Practice: Patients with salivary gland extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) have an excellent prognosis, particularly those with associated Sjögren's disease. A wide range of available therapies may provide similar durable rates of disease control and survival. Therefore, an important goal in selection of therapy should be to minimize morbidity from treatment. When determining initial therapy for these patients, practitioners should consider the potential side effects and long-term toxicities of treatment.
A recurrent vesiculobullous eruption on the head, trunk, and extremities
Beasley, Jenna M, Sluzevich, Jason C. , Sluzevich, Jason C

International Journal of Dermatology | August 12, 2015 | Volume: 55 | Issue: 2 | Pages: 149-150

10.1111/ijd.13001 | PMID 26267135 Get It

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
Woods, Beth , Hawkins, Neil , Mealing, Stuart , Sutton, Alex J. , Abraham, William T. , Beshai, John F., Klein, H. H., Sculpher, Mark , Plummer, Chris , Cowie, Martín , Cowie, Martin R

Heart | August 12, 2015 | Volume: 101 | Issue: 22 | Pages: 1800-1806

10.1136/heartjnl-2015-307634 | PMID 26269413 Get It

Objective Implantable cardioverter defibrillators (ICD), cardiac resynchronisation therapy pacemakers (CRT-P) and the combination therapy (CRT-D) have been shown to reduce all-cause mortality compared with medical therapy alone in patients with heart failure and reduced EF. Our aim was to synthesise data from major randomised controlled trials to estimate the comparative mortality effects of these devices and how these vary according to patients’ characteristics. Methods Data from 13 randomised trials (12 638 patients) were provided by medical technology companies. Individual patient data were synthesised using network meta-analysis. Results Unadjusted analyses found CRT-D to be the most effective treatment (reduction in rate of death vs medical therapy: 42% (95% credible interval: 32–50%), followed by ICD (29% (20–37%)) and CRT-P (28% (15–40%)). CRT-D reduced mortality compared with CRT-P (19% (1–33%)) and ICD (18% (7–28%)). QRS duration, left bundle branch block (LBBB) morphology, age and gender were included as predictors of benefit in the final adjusted model. In this model, CRT-D reduced mortality in all subgroups (range: 53% (34–66%) to 28% (−1% to 49%)). Patients with QRS duration ≥150 ms, LBBB morphology and female gender benefited more from CRT-P and CRT-D. Men and those <60 years benefited more from ICD. Conclusions These data provide estimates for the mortality benefits of device therapy conditional upon multiple patient characteristics. They can be used to estimate an individual patient's expected relative benefit and thus inform shared decision making. Clinical guidelines should discuss age and gender as predictors of device benefits.
Bed rest, then rehab
Lanza, Ian R. , Lanza, Ian R

Science Translational Medicine | August 12, 2015 | Volume: 7 | Issue: 300 | Pages: No page available

10.1126/scitranslmed.aad0226 Get It

Older adults are more susceptible to muscle loss during bed rest, but exercise effectively reverses these detrimental effects.
Meta-analysis comparing early versus delayed laparoscopic cholecystectomy for acute cholecystitis
Wu, Xiangdong , Tian, Xu , Liu, M -M, Wu, Lei , Zhao, Siya , Zhao, Lei , Liu, M -M

British Journal of Surgery | August 12, 2015 | Volume: 102 | Issue: 11 | Pages: 1302-1313

10.1002/bjs.9886 | PMID 26265548 Get It

Abstract Background Previous studies comparing early laparoscopic cholecystectomy (ELC) with delayed laparoscopic cholecystectomy (DLC) for acute cholecystitis were incomplete. A meta-analysis was undertaken to compare the cost-effectiveness, quality of life, safety and effectiveness of ELC versus DLC. Methods PubMed, Embase, the Cochrane Library and Web of Science were searched for randomized clinical trials (RCTs) that compared ELC (performed within 7 days of symptom onset) with DLC (undertaken at least 1 week after symptoms had subsided) for acute cholecystitis. Results Sixteen studies reporting on 15 RCTs comprising 1625 patients were included. Compared with DLC, ELC was associated with lower hospital costs, fewer work days lost (mean difference (MD) –11·07 (95 per cent c.i. –16·21 to −5·94) days; P &lt; 0·001), higher patient satisfaction and quality of life, lower risk of wound infection (relative risk 0·65, 95 per cent c.i. 0·47 to 0·91; P = 0·01) and shorter hospital stay (MD −3·38 (−4·23 to −2·52) days; P &lt; 0·001), but a longer duration of operation (MD 11·12 (4·57 to 17·67) min; P &lt; 0·001). There were no significant differences between the two groups in mortality, bile duct injury, bile leakage, conversion to open cholecystectomy or overall complications. Conclusion For patients with acute cholecystitis, ELC appears as safe and effective as DLC. ELC might be associated with lower hospital costs, fewer work days lost, and greater patient satisfaction.